Economic analysis in dermatology - 01/09/11
Abstract |
Cost-effectiveness studies are rising in importance as means for justifying expenditures on health interventions and as guides for making treatment and resource allocation decisions. However, the term “cost-effective” often is used erroneously, attributed to therapies that have not been subjected to rigorous cost analysis or comparison to an appropriate alternative. Health economic studies include cost-of-illness, cost-minimization, cost-effectiveness, cost-utility, and cost-benefit analyses. Each of these types of analyses differs in what it measures and under what circumstances its use is appropriate. This article describes the different types of economic studies, using examples to highlight their key features, and provides a summary of the key components of an economic analysis including perspective, cost and outcomes measurement, time horizon, cost-discounting, and sensitivity analysis. (J Am Acad Dermatol 2002;46:271-83.)
Le texte complet de cet article est disponible en PDF.Plan
Ms Reiter is a doctoral student in Health Services Organization and Policy in the University of Michigan School of Public Health. |
|
Reprint requests: Charles N. Ellis, MD, Department of Dermatology, 1910 A. Alfred Taubman Center, University of Michigan Medical School, Ann Arbor, MI 48109-0314. |
Vol 46 - N° 2
P. 271-283 - février 2002 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?